U.S. federal trademark · Serial No. 75148647 · Reg. No. 2179179
pharmaceutical preparations which act by modulating gene expression for the treatment of neoplastic diseases, pathological conditions characterized by cellular hyperproliferation, pathological conditions characterized by over expression of a gene, pathological conditions characterized by undesired expression of a foreign gene [, and diseases caused by viral or bacterial agents]
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.